Brown LK, Kanagasabai T, Li G, Celada SI, et al. Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis. Prostate 2024 Apr 11. doi: 10.1002/pros.24706.
PMID: 38605532